N/A
Completed N=47
Effects of Hippotherapy on Physical Fitness and Attention in Cerebral Palsy
Cerebral Palsy · Physical Activity · Attention Disorder
Source: ClinicalTrials.gov NCT03870893 ↗
Enrolled (actual)
47
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcomePrimary: Change of Clinical Global Improvement(CGI) — -0.13; -0.09; 2.65; 3.87 score on a scale
Summary
This research analyzes whether hippotherapy improves the physical activity, cardiopulmonary fitness, and attention in children with cerebral palsy and whether this enhances their general health and quality of life.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change of Clinical Global Improvement(CGI) |
-0.13; -0.09; 2.65; 3.87 | — |
| SECONDARY Change of Attention |
57.52; 57.70; 54.61; 55.39 | — |
| SECONDARY Change of Physical Activity(%) |
1.86; -0.61; -1.58; 0.24; -0.28; 0.13 | — |
| SECONDARY Change of Peak Oxygen Uptake(VO2peak) |
1.84; -0.09 | — |
| SECONDARY Change of Gross Motor Function Measure 66 |
2.24; 0.81 | — |
| SECONDARY Change of Physical Activity(Steps) |
-37.97; 20.94 | — |
| SECONDARY Change of Resting Heart Rate(RHR) |
-12.40; -0.62 | — |
| SECONDARY Change of Respiratory Exchange Ratio(RER) |
0.04; 0.01 | — |
| SECONDARY Change of Heart Rate Recovery(HRR) |
6.54; -2.15; 13.38; -5.54; 11.15; -3.80 | — |
| SECONDARY Change of Children Health Questionnaire Parent Form 50 (CHQ-PF50) |
2.73; 2.08; 3.31; 2.50 | — |
| SECONDARY Change of Timed up and go(TUG) |
-1.55; -1.33 | — |
| SECONDARY Change of 6 Minute Walk Test(6MWT) |
37.22; 13.43 | — |
| SECONDARY Change of Blood Pressure(BP) |
-1.30; 0.05; -1.55; 0.52 | — |
| SECONDARY Change of Pediatric Balance Scale(PBS) |
2.48; 0.30 | — |
| SECONDARY Change of Attention Deficit Hyperactivity Disorder (ADHD) Rating Scale |
12.22; 11.13; 11.17; 10.26 | — |
| SECONDARY Change of Self-Esteem Scale |
31.22; 32.48; 32.35; 33.34 | — |
| SECONDARY Change of PedsQL 4.0 |
60.73; 65.90; 69.70; 77.85; 70.22; 69.57 | — |
| SECONDARY Change of Continuous Performance Test 3rd Edition |
59.00; 54.00; 52.57; 49.61; 71.70; 59.91 | — |
| SECONDARY Change of Quantitative Electroencephalography |
0.384; -0.046; 0.522; -0.098; 0.501; 0.058 | — |
Eligibility Criteria
Inclusion Criteria
- diagnosis of spastic CP
- GMFCS level I-III
- weight < 35kg
- ability to walk independently with or without an assistive device
- ability to comply with the study protocol and follow verbal directions
Exclusion Criteria
- botulinum toxin injection within 3 months
- orthopedic surgery within 1 year (difficulty performing one step instructions)
- moderate to severe intellectual disability
- uncontrolled seizure
- poor visual or hearing acuity
- patients who weigh more than 35 kg
- hip dislocation
- scoliosis more than 30 degrees
- musculoskeletal surgery within 1 year
Data sourced from ClinicalTrials.gov (NCT03870893). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.